AI-PROGNOSIS was presented at Vitalis 2026, the largest medtech and eHealth conference and exhibition in the Nordic region, held on 4–7 May 2026 with 7,000 participants.

The presentation, titled “Balancing hope and harm: A qualitative exploration of ethical aspects of using AI in Parkinson's Disease”, was delivered by AI-PROGNOSIS project partner Uppsala University.

It was based on the recent publication “A Qualitative Exploration of Ethical Aspects of Using AI in Parkinson Disease: Patient Panel Study”.

As rates of Parkinson’s disease continue to rise, so does interest in using predictive artificial intelligence to support care and self-care. The presentation explored how people with Parkinson’s themselves feel about these technologies.

Drawing primarily on a qualitative study with a patient panel in a European project developing predictive AI tools, the session examined how participants view AI-driven risk prediction, prognosis, and medication response tools.

The presentation also discussed practical implications for responsible implementation, emphasizing the need to actively involve people with Parkinson’s in development and decision-making, ensure appropriate communication of sensitive predictions, and build safeguards to prevent harm and widening inequalities.